Login / Signup

Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: A cohort study.

Francesco ZaccardiPui San TanCarol CouplandBaiju R ShahAsh Kieran CliftDefne SaatciMartina PatoneSimon J GriffinHajira Dambha-MillerKamlesh Khunti F MedSciJulia Hippisley-Cox
Published in: Diabetes, obesity & metabolism (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • early onset
  • human health
  • blood glucose
  • respiratory syndrome coronavirus
  • metabolic syndrome
  • glycemic control
  • insulin resistance